
|Videos|October 11, 2016
Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
Advertisement
Episodes in this series

Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Ed Pezalla, MD, MPH, discuss determining and recognizing utilization management for long-term systemic therapies in patients with atopic dermatitis.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Hypertension Guideline: Key Shifts for Pharmacists
2
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
3
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
4
The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question
5

























































































































